Safety and Pharmacokinetics of an Extract of Naringenin

Completed · Early Phase 1 · Has a placebo group

Conditions studied: Safety Issues, Pharmacokinetics

In brief

This study evaluates the safety of administering single ascending doses (150, 300, 600, and 900 mg) of a citrus extract of the flavonoid narigenin, and assesses the blood concentrations of naringenin following oral administration of the extract.

Key facts

Study ID
NCT03582553
Run by
Pennington Biomedical Research Center
People needed
18
Starts
2018-05-25
Expected to finish
2018-09-28
Last updated by the study team
2020-01-18

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.